Your browser doesn't support javascript.
loading
A randomized controlled pilot trial of anakinra for hemodialysis inflammation.
Dember, Laura M; Hung, Adriana; Mehrotra, Rajnish; Hsu, Jesse Y; Raj, Dominic S; Charytan, David M; Mc Causland, Finnian R; Regunathan-Shenk, Renu; Landis, J Richard; Kimmel, Paul L; Kliger, Alan S; Himmelfarb, Jonathan; Ikizler, T Alp.
Afiliación
  • Dember LM; Renal, Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvan
  • Hung A; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Vanderbilt O'Brien Kidney Center, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Veterans Affairs, Tennessee Valley Healthcare S
  • Mehrotra R; Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington, USA; Division of Nephrology, Department of Medicine, Harborview Medical Center, University of Washington, Seattle, Washington, USA.
  • Hsu JY; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Raj DS; Division of Renal Diseases and Hypertension, George Washington University School of Medicine, Washington, DC, USA.
  • Charytan DM; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Mc Causland FR; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
  • Regunathan-Shenk R; Division of Renal Diseases and Hypertension, George Washington University School of Medicine, Washington, DC, USA.
  • Landis JR; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kimmel PL; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Kliger AS; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA; Yale New Haven Health System, New Haven, Connecticut, USA.
  • Himmelfarb J; Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington, USA. Electronic address: himmej@uw.edu.
  • Ikizler TA; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Vanderbilt O'Brien Kidney Center, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Veterans Affairs, Tennessee Valley Healthcare S
Kidney Int ; 102(5): 1178-1187, 2022 11.
Article en En | MEDLINE | ID: mdl-35863559
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diálisis Renal / Proteína Antagonista del Receptor de Interleucina 1 / Inflamación Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Revista: Kidney Int Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diálisis Renal / Proteína Antagonista del Receptor de Interleucina 1 / Inflamación Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Revista: Kidney Int Año: 2022 Tipo del documento: Article